Natac Natural Ingredients, S.A. (BME:NAT)
0.5700
-0.0050 (-0.87%)
Jul 17, 2026, 5:29 PM CET
Natac Natural Ingredients Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.4 | 0.57 | 1.61 | 0.83 | 0.03 |
Short-Term Investments | 0.04 | 0.13 | 0.1 | 0.87 | 1.41 |
Cash & Short-Term Investments | 1.44 | 0.7 | 1.72 | 1.7 | 1.44 |
Cash Growth | 105.11% | -59.11% | 0.79% | 18.24% | 123.61% |
Accounts Receivable | 11.14 | 4.33 | 10.15 | 0 | 0.65 |
Other Receivables | 1.43 | 4.67 | 2.54 | 0.07 | 0.07 |
Total Trade Receivables | 12.57 | 9 | 12.69 | 0.07 | 0.72 |
Restricted Cash | - | - | - | - | 0 |
Inventory | 14.86 | 18.76 | 16.17 | - | 0.77 |
Other Current Assets | 0.03 | 0.04 | 0.01 | 0.01 | 0 |
Total Current Assets | 28.9 | 28.5 | 30.59 | 1.85 | 2.93 |
Net Property, Plant & Equipment | 43.36 | 35.09 | 25.96 | 0.01 | 1.48 |
Other Intangible Assets | 12.64 | 16.87 | - | - | 3.25 |
Goodwill | 48.68 | 48.68 | - | - | 33.49 |
Long-Term Investments | 4.78 | 4.31 | 12.22 | 13.97 | 2.34 |
Other Long-Term Assets | 2.44 | 1.87 | 0.74 | - | 1.06 |
Total Assets | 140.8 | 135.31 | 128.08 | 15.83 | 44.56 |
Accounts Payable | 4.06 | 7.41 | 5.15 | 0.05 | 0.5 |
Accrued Expenses | 4.1 | 2.27 | 1.21 | 0.05 | 0.29 |
Short-Term Debt | 34.12 | 25.28 | 22.2 | 0.08 | 0.86 |
Current Portion of Leases | 0.23 | 0.24 | 0.15 | - | - |
Unearned Revenue | 0.01 | 0.08 | 0.04 | - | - |
Other Current Liabilities | 7.58 | 7.62 | 3.37 | 0.98 | 3.33 |
Total Current Liabilities | 50.11 | 42.9 | 32.11 | 1.55 | 4.12 |
Long-Term Debt | 34.27 | 37.46 | 38.44 | 9.22 | 2.46 |
Long-Term Leases | 0.22 | 0.36 | 0.18 | - | - |
Other Long-Term Liabilities | 11.2 | 11.89 | 13.37 | - | 2.46 |
Total Long-Term Liabilities | 45.69 | 49.71 | 51.99 | 9.22 | 2.46 |
Total Liabilities | 95.8 | 92.61 | 84.11 | 10.77 | 6.58 |
Common Stock | 3.48 | 86.97 | 83.78 | 7.56 | 46 |
Treasury Stock | -2.06 | -2.19 | -0.39 | -0.1 | -0 |
Additional Paid-in Capital | 11.41 | 66.19 | 65.81 | 1.8 | - |
Accumulated Other Comprehensive Income | 0.08 | -0.33 | -0.11 | - | - |
Retained Earnings | 32.09 | -107.94 | -107.66 | -4.2 | -8.91 |
Total Common Shareholders' Equity | 44.92 | 43.03 | 41.55 | 5.05 | 37.67 |
Minority Interest | - | - | 2.53 | - | 0.31 |
Shareholders' Equity | 45 | 42.7 | 43.97 | 5.05 | 37.99 |
Total Liabilities & Equity | 140.8 | 135.31 | 128.08 | 15.83 | 44.56 |
Total Debt | 68.84 | 63.34 | 60.97 | 9.29 | 3.32 |
Net Cash (Debt) | -67.4 | -62.64 | -59.26 | -7.59 | -1.88 |
Net Cash Per Share | -0.16 | -0.14 | -0.14 | -0.20 | -0.08 |
Book Value | 44.92 | 43.03 | 41.55 | 5.05 | 37.67 |
Book Value Per Share | 0.10 | 0.10 | 0.10 | 0.13 | 1.64 |
Tangible Book Value | -16.39 | -22.52 | 41.55 | 5.05 | 0.93 |
Tangible Book Value Per Share | -0.04 | -0.05 | 0.10 | 0.13 | 0.04 |